stockrowHaleon PLC Sponsored ADR (HLN) vs Takeda Pharmaceutical Co. (TAK)
- Haleon PLC Sponsored ADR HLN 9.13 −1.08%
- Takeda Pharmaceutical Co. TAK 21.25 +0.90%
Haleon PLC Sponsored ADR and Takeda Pharmaceutical Co. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $67.7B against $40.2B — 1.7× the size. Haleon PLC Sponsored ADR trades at the lower P/E: 20.5× against 32.0×. Haleon PLC Sponsored ADR has the higher net margin (11.2% vs 7.12%) and the higher return on invested capital (0.00% vs 0.00%). Both pay a dividend; Haleon PLC Sponsored ADR yields more (2.16% vs 1.45%). Across the 18 metrics below, Haleon PLC Sponsored ADR leads on 11 and Takeda Pharmaceutical Co. on 7.
Valuation
Profitability
| Metric | HLN | TAK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.22% | 65.85% | 53.51% |
| Operating margin | 17.93% | 11.61% | 0.00% |
| Net margin | 11.18% | 7.12% | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (0.80%) |
| Return on assets | 0.00% | 0.00% | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack